Skip to main content
SYNLAB AG logo

SYNLAB AG — Investor Relations & Filings

Ticker · SYAB ISIN · DE000A2TSL71 LEI · 984500883BA5AQ14C037 F Human health and social work activities
Open in API
Filings indexed 152 across all filing types
Latest filing 2021-04-19 Share Issue/Capital Cha…
Country DE Germany
Listing F SYAB

About SYNLAB AG

https://www.synlab.com/

SYNLAB AG is a leading provider of medical laboratory diagnostic services. The company offers a comprehensive portfolio of over 5,000 routine and specialty tests across various medical disciplines, including human genetics and anatomical pathology. Its services provide essential diagnostic information for doctors, clinics, and patients, playing a vital role in clinical decision-making throughout the entire patient care process, from prevention and diagnosis to treatment and monitoring.

Recent filings

Filing Released Lang Actions
SYNLAB sets price range for its planned IPO at EUR 18.00 to EUR 23.00 per share
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing the setting of the price range for SYNLAB AG's planned Initial Public Offering (IPO). Key phrases include "SYNLAB sets price range for its planned IPO," "Total size of the offering set to exceed EUR 1 billion," and details about the offer period, expected trading date, and use of proceeds (debt reduction). This content directly relates to fundraising, capital structure changes, and the issuance of new shares to the public market. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it involves share issuance (SHA) and is a public announcement, the primary focus is the financing event (the IPO pricing and structure), making CAP the most specific fit. It is not a full 10-K, an ER, or a simple DIV notice.
2021-04-19 English
Synlab plans initial public offering
Capital/Financing Update Classification · 98% confidence The document is a press release dated April 7, 2021, announcing that SYNLAB AG 'plans initial public offering' (IPO). It details the intention to list on the Frankfurt Stock Exchange, the structure of the offering (newly created shares and secondary component), expected proceeds, and future financial guidance. This announcement relates directly to a major financing and capital structure event (raising capital via an IPO). This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is an announcement, it is the primary document detailing the financing event itself, rather than just announcing the publication of a separate report (which would be RPA/RNS).
2021-04-07 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.